The pharmaceutical trade between India and Antigua and Barbuda has experienced a notable evolution over the past two decades. In 2005, Antigua and Barbuda's exports of medicinal and pharmaceutical products peaked at approximately $126.66 million. However, by 2024, this figure had declined to around $20.09 million, indicating a significant reduction in export value. Despite this downturn, India's pharmaceutical exports to Antigua and Barbuda have shown resilience. In 2024, India exported pharmaceutical products valued at $410,360 to Antigua and Barbuda, marking a steady presence in the market. This consistent trade underscores the enduring nature of the bilateral pharmaceutical relationship.
The growth trajectory of this trade corridor has been characterized by gradual expansion. Between 2022 and 2026, India exported a total of $538,000 worth of pharmaceutical products to Antigua and Barbuda, distributed across 1,533 shipments from 33 Indian exporters to 38 buyers in Antigua and Barbuda. The average shipment value during this period was $351, reflecting a steady demand for Indian pharmaceutical products. The top Indian exporters in this corridor include Vama Lifecare Private Limited, Sunny Pharma, Lotus International, Vea Impex (I) Private Limited, and Gland Pharma Ltd, collectively contributing to the sustained trade volume.
